Latest RNS Announcements
June 02, 2023
Notice of AGM
May 18, 2023
Holding(s) in Company
May 15, 2023
Audited Results for the Year Ended 31 December 2022 & Investor Presentation
May 15, 2023
Transfer of ToxHub Platform and launch of Centrus®
May 11, 2023
Holding(s) in Company
May 11, 2023
US Government Contract Award
May 04, 2023
Holding(s) in Company
May 03, 2023
Notice of Results and Investor Presentation
May 03, 2023
Exercise of Options, Issue of Equity & Total Voting Rights
April 14, 2023
Holding(s) in Company
March 13, 2023
No Exposure to Silicon Valley Bank
January 31, 2023
Trading Update
January 09, 2023
Appointment of Independent Non-Executive Director
December 22, 2022
Contract Extension with Leading CRO
November 30, 2022
Holding(s) in Company
October 12, 2022
Exercise of Options, Issue of Equity and Total Voting Rights
September 27, 2022
Half Year Report
September 27, 2022
Settlement of Historical Contractual Licence Dispute
September 13, 2022
Notice of Results and Investor Presentation
September 09, 2022
Holding(s) in Company
September 02, 2022
$12m five-year agreement with Leading Contract Research Organisation
August 04, 2022
Half Year Trading Update
June 29, 2022
Holding(s) in Company
June 09, 2022
Result of AGM
May 20, 2022
Holding(s) in Company
May 17, 2022
Notice of AGM & Posting of Annual Report
May 03, 2022
Holding(s) in Company
May 03, 2022
European Medicines Agency Research Grant
April 26, 2022
Unaudited Results for the Year Ended 31 December 2021 & Investor Presentation
April 26, 2022
Earn Outs and Deferred Payments
March 15, 2022
Grant of PDMR Options
March 14, 2022
Exercise of Options, Issue of Equity and Total Voting Rights
March 14, 2022
Holding(s) in Company
February 21, 2022
Holding(s) in Company
February 04, 2022
Exercise of Options, PDMR Dealing, Issue of Equity and Total Voting Rights
January 26, 2022
Trading Update
January 11, 2022
Appointment of Stifel as Joint Broker
December 21, 2021
H2 China Market Update
December 13, 2021
Holding(s) in Company
November 25, 2021
Holding(s) in Company
November 22, 2021
New In Silico Software Release
November 22, 2021
Holding(s) in Company
October 11, 2021
Director/PDMR Dealings
September 29, 2021
Holding(s) in Company
September 29, 2021
Appointment of Independent Non-Executive Director
September 28, 2021
Grant of PDMR Options
September 27, 2021
Half Year Report
September 14, 2021
Notice of Results and Investor Presentation
September 14, 2021
Exercise of Options, Issue of Equity and Total Voting Rights
September 01, 2021
Earnings Enhancing Acquisition of PDS Pathology Data Systems
July 19, 2021
Half Year Trading Update
June 16, 2021
Holding(s) in Company
June 14, 2021
Notice of Capital Markets Day
May 27, 2021
Result of AGM
May 11, 2021
Holding(s) in Company
May 06, 2021
Holding(s) in Company
April 20, 2021
Exercise of Options, Issue of Equity and Total Voting Rights
April 19, 2021
Grant of Options
April 19, 2021
Notification of Major Holdings
April 15, 2021
Notification of Major Holdings
April 12, 2021
Audited Results for the Year Ended 31 December 2020 & Investor Presentation
April 01, 2021
Completion of Acquisition of d-wise, Issue of Equity and Total Voting Rights
March 31, 2021
Notice of Results
March 22, 2021
Earnings Enhancing Acquisition of d-wise and Investor Presentation
March 01, 2021
Earnings Enhancing Acquisition of The Edge
January 14, 2021